The efficacy of ceftazidime on bacterial otitis

Phase 3

• Conditions: Bacterial otitis externa.; Unspecified otitis externa, unspecified ear; H60.90

• Registration Number: IRCT20130427013136N6
• Lead Sponsor: Babol University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 24 February 2020

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

All patients with bacterial otitis externa.

Exclusion Criteria

Patients who have fungal infections.
Patients who have tympanic membranous perforation
Patients with a history of ear surgery.
Patients with defective ear canal.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: En Severity of pain will determined by the patient's expression or pain index (Visual Analog Scale-VAS) which are between 0-10.;Swelling. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Severity of swelling will determine based on the examination of the ear by the physician.;Secretion. Timepoint: Before intervention and 2 weeks after intervention. Method of measurement: Severity of secretion will determine based on the examination of the ear by the physician.